Understanding DSB repair mechanisms has significant clinical implications. For instance, many cancer therapies such as radiation and certain chemotherapeutics work by inducing DSBs to kill cancer cells. However, resistance can develop if cancer cells upregulate their DSB repair pathways. Therefore, researchers are exploring inhibitors of key DSB repair proteins as potential adjuvant therapies to enhance the efficacy of existing treatments.
